Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Sitthichai Iamsaard, Somboon Kietinun, Jintana Sattayasai, Kingkan Bunluepuech, Alexander Tsang-Hsien Wu & Pannawat Choowong-In. (2023) Prevention of seminal vesicle damage by Mucuna pruriens var. pruriens seed extract in chronic unpredictable mild stress mice. Pharmaceutical Biology 61:1, pages 89-99.
Read now
Read now
C. Brendan Montano, W. Clay Jackson, Denise Vanacore & Richard Weisler. (2023) Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression. Postgraduate Medicine 135:5, pages 449-465.
Read now
Read now
Jaqueline G. Borges-Vieira & Camila K. Souza Cardoso. (2023) Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials. Nutritional Neuroscience 26:3, pages 187-207.
Read now
Read now
Ellen Van Leeuwen, Sibyl Anthierens, Mieke L. van Driel, An I. M. De Sutter, Evelien van den Branden & Thierry Christiaens. (2022) General practitioners’ perspectives on discontinuation of long-term antidepressants in nursing homes. European Journal of General Practice 28:1, pages 23-31.
Read now
Read now
Ellen Van Leeuwen, Sibyl Anthierens, Mieke L van Driel, An De Sutter, Rani De Beir & Thierry Christiaens. (2022) Should I, can I, dare I? Patients’ view on stopping long-term antidepressant use, a qualitative study. Acta Clinica Belgica 77:6, pages 962-969.
Read now
Read now
Behnaz Abiri, Parvin Sarbakhsh & Mohammadreza Vafa. (2022) Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms. Nutritional Neuroscience 25:10, pages 2123-2135.
Read now
Read now
Van Leeuwen Ellen, Sibyl Anthierens, Mieke L. van Driel, An De Sutter, Evelien van den Branden & Thierry Christiaens. (2021) ‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants. Scandinavian Journal of Primary Health Care 39:4, pages 533-542.
Read now
Read now
Carlotta Lunghi, Ippazio Cosimo Antonazzo, Sofia Burato, Emanuel Raschi, Violetta Zoffoli, Emanuele Forcesi, Elisa Sangiorgi, Marco Menchetti, Pasquale Roberge & Elisabetta Poluzzi. (2020) Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study. Neuropsychiatric Disease and Treatment 16, pages 1157-1170.
Read now
Read now
William Beedham, Antonio Belli, Sathana Ingaralingam, Sayeed Haque & Rachel Upthegrove. (2020) The management of depression following traumatic brain injury: A systematic review with meta-analysis. Brain Injury 34:10, pages 1287-1304.
Read now
Read now
Kyle T. Greenway, Nicolas Garel, Lisa Jerome & Allison A. Feduccia. (2020) Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology 13:6, pages 655-670.
Read now
Read now
Jacquelyn H. Flaskerud. (2019) Undisclosed Consequences of Drug Use. Issues in Mental Health Nursing 40:2, pages 187-190.
Read now
Read now
Articles from other publishers (83)
Marie Crowe, Jenni Manuel, Dave Carlyle & Cameron Lacey. (2023) Experiences of psilocybin treatment for clinical conditions: A qualitative meta‐synthesis. International Journal of Mental Health Nursing 32:4, pages 1025-1037.
Crossref
Crossref
Vasilios G. Masdrakis, Manolis Markianos & David S. Baldwin. (2023) Apathy associated with antidepressant drugs: a systematic review. Acta Neuropsychiatrica 35:4, pages 189-204.
Crossref
Crossref
Muhammad Youshay Jawad, Maurish Fatima, Umer Hassan, Zaofashan Zaheer, Muhammad Ayyan, Muhammad Ehsan, Muhmmad Huzaifa Ahmed Khan, Ahsan Qadeer, Abdul Rehman Gull, Muhammad Talha Asif & Mujeeb U. Shad. (2023) Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature. Human Psychopharmacology: Clinical and Experimental.
Crossref
Crossref
Samantha Klaas, Jessica Barbut Siva, Maarten Bak, Mark Govers & Rudy Schreiber. (2023) The pathophysiology of Post SSRI Sexual Dysfunction – Lessons from a case study. Biomedicine & Pharmacotherapy 161, pages 114166.
Crossref
Crossref
Erika Plazas & Nicoletta Faraone. (2023) Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents. Biomedicines 11:2, pages 461.
Crossref
Crossref
Zuzanna Chrzastek, Agnieszka Guligowska, Piotr Sobczuk & Tomasz Kostka. (2023) Dietary factors, risk of developing depression, and severity of its symptoms in older adults—A narrative review of current knowledge. Nutrition 106, pages 111892.
Crossref
Crossref
Seema Mehdi, Kishor Manohar, Atiqulla Shariff, Nabeel Kinattingal, Shahid Ud Din Wani, Sultan Alshehri, Mohammad T. Imam, Faiyaz Shakeel & Kamsagara L. Krishna. (2023) Omega-3 Fatty Acids Supplementation in the Treatment of Depression: An Observational Study. Journal of Personalized Medicine 13:2, pages 224.
Crossref
Crossref
Zachary D. Cohen, Robert J. DeRubeis, Rachel Hayes, Edward R. Watkins, Glyn Lewis, Richard Byng, Sarah Byford, Catherine Crane, Willem Kuyken, Tim Dalgleish & Susanne Schweizer. (2022) The Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication. Clinical Psychological Science 11:1, pages 59-76.
Crossref
Crossref
Susan dosReis, Laura M. Bozzi, Beverly Butler, Richard Z. Xie, Richard H. Chapman, Jennifer Bright, Erica Malik & Julia F. Slejko. (2022) Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience. The Patient - Patient-Centered Outcomes Research 16:1, pages 57-66.
Crossref
Crossref
Amy Coe, Jane Gunn & Catherine Kaylor-Hughes. (2022) General Practice Patients’ Experiences and Perceptions of the WiserAD Structured Web-Based Support Tool for Antidepressant Deprescribing: Protocol for a Mixed Methods Case Study With Realist Evaluation. JMIR Research Protocols 11:12, pages e42526.
Crossref
Crossref
Elliot Marseille, Stefano Bertozzi & James G. Kahn. (2022) The economics of psychedelic-assisted therapies: A research agenda. Frontiers in Psychiatry 13.
Crossref
Crossref
Frederick H. F. Chan, Xiaowen Lin, Konstadina Griva, Mythily Subramaniam, Ivan Ćelić & Lorainne Tudor Car. (2022) Information needs and sources of information among people with depression and anxiety: a scoping review. BMC Psychiatry 22:1.
Crossref
Crossref
Astrid Chevance, Anneka Tomlinson, Philippe Ravaud, Suzanne Touboul, Catherine Henshall, Viet-Thi Tran & Andrea Cipriani. (2022) Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals. Evidence Based Mental Health 25:e1, pages e41-e48.
Crossref
Crossref
Humna Liaqat, Amna Parveen & Sun-Yeou Kim. (2022) Antidepressive Effect of Natural Products and Their Derivatives Targeting BDNF-TrkB in Gut–Brain Axis. International Journal of Molecular Sciences 23:23, pages 14968.
Crossref
Crossref
Hu Jieqiong, Ji Yunxin, Dai Ni, Lin Chen & Chai Ying. (2022) The correlation of body mass index with clinical factors in patients with first-episode depression. Frontiers in Psychiatry 13.
Crossref
Crossref
Guixing Xu, Hanzhou Lei, Liuyang Huang, Qiwei Xiao, Biqing Huang, Zhuo Zhou, Hao Tian, Fengyuan Huang, Yilin Liu, Ling Zhao, Xiang Li & Fanrong Liang. (2022) The dose-effect association between acupuncture sessions and its effects on major depressive disorder: A meta-regression of randomized controlled trials. Journal of Affective Disorders 310, pages 318-327.
Crossref
Crossref
Pannawat Choowong-in, Jintana Sattayasai, Preecha Boonchoong, Chanasorn Poodendaen, Alexander TH. Wu, Nareelak Tangsrisakda, Tarinee Sawatpanich, Supatcharee Arun, Nongnut Uabundit & Sitthichai Iamsaard. (2022) Protective effects of Thai Mucuna pruriens (L.) DC. var. pruriens seeds on sexual behaviors and essential reproductive markers in chronic unpredictable mild stress mice. Journal of Traditional and Complementary Medicine 12:4, pages 402-413.
Crossref
Crossref
Ellison Suthoff, Mark Kosinski, Alix Arnaud, Paul Hodgkins, Handan Gunduz-Bruce, Robert Lasser, Christopher Silber, Abdul J. Sankoh, Haihong Li, Brian Werneburg, Jeffrey Jonas, James Doherty, Stephen J. Kanes & Vijayveer Bonthapally. (2022) Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder. Journal of Affective Disorders 308, pages 19-26.
Crossref
Crossref
Annie M. McCartney, Hugh T McGovern & Alexander De Foe. (2022) Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions. Journal of Psychedelic Studies 6:1, pages 10-22.
Crossref
Crossref
Shanquan Chen, Tamsin J. Ford, Peter B. Jones & Rudolf N. Cardinal. (2022) Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: A repetitive cross-sectional study in 19 European countries. The Lancet Regional Health - Europe 17, pages 100368.
Crossref
Crossref
Khushboo, Nikhat J. Siddiqi, Maria de Lourdes Pereira & Bechan Sharma. (2022) Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants. Molecular Neurobiology 59:6, pages 3564-3584.
Crossref
Crossref
C Brendan Montano, W Clay Jackson, Denise Vanacore & Richard H Weisler. (2022) Practical Advice for Primary Care Clinicians on the Safe and Effective Use of Vortioxetine for Patients with Major Depressive Disorder (MDD). Neuropsychiatric Disease and Treatment Volume 18, pages 867-879.
Crossref
Crossref
Su-Gwan Tham, Nicky Lidbetter, Rebecca Pedley, Dave Smithson, Beatrice Lukoseviciute & Patricia Gooding. (2022) An evaluation of Anxiety UK's psychological therapy service outcomes. Journal of Affective Disorders 301, pages 478-485.
Crossref
Crossref
Caroline S. Clarke, Larisa Duffy, Glyn Lewis, Nick Freemantle, Simon Gilbody, Tony Kendrick, David Kessler, Michael King, Paul Lanham, Derelie Mangin, Michael Moore, Irwin Nazareth, Nicola Wiles, Louise Marston & Rachael Maree Hunter. (2021) Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study. Applied Health Economics and Health Policy 20:2, pages 269-282.
Crossref
Crossref
Timothy Wand, Suzanne Glover & Diane Paul. (2021) What should be the future focus of mental health nursing? Exploring the perspectives of mental health nurses, consumers, and allied health staff. International Journal of Mental Health Nursing 31:1, pages 179-188.
Crossref
Crossref
Laura de Anta, Miguel Angel Alvarez-Mon, Miguel A. Ortega, Cristina Salazar, Carolina Donat-Vargas, Javier Santoma-Vilaclara, Maria Martin-Martinez, Guillermo Lahera, Luis Gutierrez-Rojas, Roberto Rodriguez-Jimenez, Javier Quintero & Melchor Alvarez-Mon. (2022) Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study. Journal of Personalized Medicine 12:2, pages 155.
Crossref
Crossref
Miriam Boland, Agnes Higgins, Claire Beecher, Pat Bracken, Wendy Burn, Anne Cody, Adele Framer, Toto Anne Gronlund, Mark Horowitz, Christy Huff, Sandra Jayacodi, Dolores Keating, David Kessler, Asa Konradsson Geuken, Nicole Lamberson, Luke Montagu, Brian Osborne, Ruth Smith & Cathal Cadogan. (2022) Priorities for future research on reducing and stopping psychiatric medicines using a James Lind Alliance priority setting partnership: The PROTECT study protocol. HRB Open Research 5, pages 72.
Crossref
Crossref
Janelle W. Coughlin, Kristine J. Steffen, Sanjeev Sockalingam & James E. Mitchell. (2022) Psychotropic Medications in Metabolic and Bariatric Surgery: Research Updates and Clinical Considerations. Current Psychiatry Reports 24:1, pages 89-98.
Crossref
Crossref
Gerhard Zarbock, Paula-Sophie Stürzel & Nicolai SemmlerGerhard Zarbock, Paula-Sophie Wilckens & Nicolai Semmler. 2022. Biografisch-Systemische Verhaltenstherapie. Biografisch-Systemische Verhaltenstherapie
87
167
.
Hongzhe Ma, Min Cai & Huaning Wang. (2021) Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research. Frontiers in Psychiatry 12.
Crossref
Crossref
Stephanie G Six, Kaileigh A Byrne, Thomas P Tibbett & Irene Pericot-Valverde. (2021) Examining the Effectiveness of Gamification in Mental Health Apps for Depression: Systematic Review and Meta-analysis. JMIR Mental Health 8:11, pages e32199.
Crossref
Crossref
Przemysław Sołek, Jennifer Mytych, Anna Tabęcka-Łonczyńska & Marek Koziorowski. (2021) Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects. International Journal of Molecular Sciences 22:21, pages 11855.
Crossref
Crossref
Branden Cahill, Samuel Poelker-Wells, Jonathan F. Prather & Yun Li. (2021) A Glimpse Into the Sexual Dimorphisms in Major Depressive Disorder Through Epigenetic Studies. Frontiers in Neural Circuits 15.
Crossref
Crossref
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, Mark Rus & David E. Olson. (2021) Psychedelics and Other Psychoplastogens for Treating Mental Illness. Frontiers in Psychiatry 12.
Crossref
Crossref
Prashant Sakharkar & Thanh Mai. (2021) Co-Occurring Depression and Associated Healthcare Utilization and Expenditure in Individuals with Respiratory Condition: A Population-Based Study. Pharmacy 9:4, pages 157.
Crossref
Crossref
Andreas Høstmælingen, Pål Ulvenes, Helene Amundsen Nissen‐Lie, Mikkel Eielsen & Bruce E. Wampold. (2021) Comparing outcomes in chronic depression following inpatient psychotherapy for patients continuing versus discontinuing antidepressant medication. Clinical Psychology & Psychotherapy 28:5, pages 1111-1127.
Crossref
Crossref
Melanie Mitsui Wong, Talha Tahir, Michael Mitsui Wong, Annilee Baron & Rachael Finnerty. (2021) Biomarkers of Stress in Music Interventions: A Systematic Review. Journal of Music Therapy 58:3, pages 241-277.
Crossref
Crossref
Aoife O'Neill, John McFarland & Dervla Kelly. (2021) Long‐term antidepressant use in a cohort of older people. International Journal of Geriatric Psychiatry 36:8, pages 1241-1251.
Crossref
Crossref
Sheikh Salim, Sonone Pankaj, Verma Veena, Tripathi Chakra Dhar, Karim Bushra Ahmed & Meshram Girish Gulab. (2021) Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?. Open Journal of Pharmacology and Pharmacotherapeutics, pages 004-008.
Crossref
Crossref
Jonathan Blackwell, Christopher Alexakis, Sonia Saxena, Hanna Creese, Alex Bottle, Irene Petersen, Matthew Hotopf & Richard C G Pollok. (2021) Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study. BMJ Open Gastroenterology 8:1, pages e000588.
Crossref
Crossref
Ellen Van Leeuwen, Mieke L van Driel, Mark A Horowitz, Tony Kendrick, Maria Donald, An IM De Sutter, Lindsay Robertson & Thierry Christiaens. (2021) Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Sheikh Salim, Sonone Pankaj, Verma Veena, Tripathi Chakar Dhar, Karim Bushra Ahmed & Meshram Girish Gulab. (2021) Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression. Journal of Neurology, Neurological Science and Disorders, pages 019-023.
Crossref
Crossref
Dervla Kelly, Justin Graffi, Maria Noonan, Philip Green, John McFarland, Peter Hayes & Liam Glynn. (2021) Exploration of GP perspectives on deprescribing antidepressants: a qualitative study. BMJ Open 11:4, pages e046054.
Crossref
Crossref
Koustuv Saha, John Torous, Emre Kiciman & Munmun De Choudhury. (2021) Understanding Side Effects of Antidepressants: Large-scale Longitudinal Study on Social Media Data. JMIR Mental Health 8:3, pages e26589.
Crossref
Crossref
Ivana Massabki & Elia Abi-Jaoude. (2020) Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal. The British Journal of Psychiatry 218:3, pages 168-171.
Crossref
Crossref
Amrit Pal Singh, Lovedeep Singh, Palwinder Singh & Rajbir Bhatti. (2021)
Biological Evaluation of
Aegle marmelos
Fruit Extract and Isolated Aegeline in Alleviating Pain
–
Depression Dyad: In Silico Analysis of Aegeline on MAO-A and iNOS
. ACS Omega 6:3, pages 2034-2044.
Crossref
Crossref
Adele Framer. (2021) What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology 11, pages 204512532199127.
Crossref
Crossref
Robyn P. Thom, Jeanne L. Alexander, David Baron, Amir Garakani, Lawrence Gross, Janet H. Pine, Rajiv Radhakrishnan, Andrew Slaby & Calvin R. Sumner. (2021) Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough?. Journal of Psychiatric Practice 27:5, pages 361-371.
Crossref
Crossref
Stephanie Six, Maggie Harris, Emma Winterlind & Kaileigh Byrne. 2021. HCI International 2021 - Late Breaking Posters. HCI International 2021 - Late Breaking Posters
197
206
.
Sheikh Salim, Sonone Pankaj, Tripathi Chakar Dhar, Verma Veena & Karim Bushra Ahmed. (2020) An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine. Annals of Psychiatry and Treatment, pages 057-061.
Crossref
Crossref
Behnaz Abiri & Mohammadreza Vafa. (2020) Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial. Trials 21:1.
Crossref
Crossref
Kadir Aşçibaşi, Fikret Poyraz Çökmüş, Didem Sücüllüoğlu Dikici, Hüseyin Murat Özkan, Deniz Alçi, Neslihan Altunsoy, Erkan Kuru, Serra Yüzeren & Ömer Aydemir. (2020) Evaluation of Emotional Adverse Effects of Antidepressants. Journal of Clinical Psychopharmacology 40:6, pages 594-598.
Crossref
Crossref
Leandro Cardozo-Batista & Adriana Marcassa Tucci. (2020) Effectiveness of an alternative intervention in the treatment of depressive symptoms. Journal of Affective Disorders 276, pages 562-569.
Crossref
Crossref
Hartej Gill, Barjot Gill, Sabine El‐Halabi, David Chen‐Li, Orly Lipsitz, Joshua Daniel Rosenblat, Tamsyn E. Van Rheenen, Nelson B. Rodrigues, Rodrigo B. Mansur, Amna Majeed, Leanna M. W. Lui, Flora Nasri, Yena Lee & Roger S. Mcintyre. (2020) Antidepressant Medications and Weight Change: A Narrative Review. Obesity 28:11, pages 2064-2072.
Crossref
Crossref
John Read, Claire Cartwright & Kerry Gibson. (2020) Are Antidepressants Overprescribed? Patients' Experiences of the Prescribing Process. Ethical Human Psychology and Psychiatry 22:2, pages 83-97.
Crossref
Crossref
Shannon Hughes, Jeffrey R Lacasse & Jennifer Spaulding-Givens. (2019) The micro-to-macro realities of antidepressant taking: Users’ experiences in the context of contested science and industry promotion. Qualitative Social Work 19:5-6, pages 1219-1237.
Crossref
Crossref
Curt Hemanny, Clara Carvalho, Nina Maia, Daniela Reis, Ana Cristina Botelho, Dagoberto Bonavides, Camila Seixas & Irismar Reis de Oliveira. (2019) Efficacy of trial-based cognitive therapy, behavioral activation and treatment as usual in the treatment of major depressive disorder: preliminary findings from a randomized clinical trial. CNS Spectrums 25:4, pages 535-544.
Crossref
Crossref
Fengmin Ding, Jiajia Wu, Chenyue Liu, Qinglai Bian, Wenqi Qiu, Qingyu Ma, Xiaojuan Li, Man Long, Xiaojuan Zou & Jiaxu Chen. (2020) Effect of Xiaoyaosan on Colon Morphology and Intestinal Permeability in Rats With Chronic Unpredictable Mild Stress. Frontiers in Pharmacology 11.
Crossref
Crossref
Filip Szkodziak, Jarosław Krzyżanowski & Piotr Szkodziak. (2020) Psychological aspects of infertility. A systematic review. Journal of International Medical Research 48:6, pages 030006052093240.
Crossref
Crossref
Jee Hyun Yi, Jieun Jeon, Huiyoung Kwon, Eunbi Cho, Jeanho Yun, Young Choon Lee, Jong Hoon Ryu, Se Jin Park, Jong Hyun Cho & Dong Hyun Kim. (2020) Rubrofusarin Attenuates Chronic Restraint Stress-Induced Depressive Symptoms. International Journal of Molecular Sciences 21:10, pages 3454.
Crossref
Crossref
Chiara Fabbri & Alessandro Serretti. (2020) Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies. Neuroscience Letters 726, pages 133651.
Crossref
Crossref
Kristen L. Syme & Edward H. Hagen. (2019) Mental health is biological health: Why tackling “diseases of the mind” is an imperative for biological anthropology in the 21st century. American Journal of Physical Anthropology 171:S70, pages 87-117.
Crossref
Crossref
Jennifer SevereJohn F. GredenPriyanka Reddy. (2020) Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?. FOCUS 18:2, pages 120-128.
Crossref
Crossref
Ellen Van Leeuwen, Mieke L van Driel, An IM De Sutter, Kristen Anderson, Lindsay Robertson & Thierry Christiaens. (2020) Discontinuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Michael P. Hengartner, Lukas Schulthess, Anders Sorensen & Adele Framer. (2020) Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Therapeutic Advances in Psychopharmacology 10, pages 204512532098057.
Crossref
Crossref
David Siles-López & Tatiana Fernández-Bianqui. (2019) Determinantes del estado de salud percibido tras padecer una depresión a través de la encuesta de salud española 2017. Revista Científica 29:1, pages 29-43.
Crossref
Crossref
Joseph Ford, Felicity Thomas, Richard Byng & Rose McCabe. (2019) Exploring how patients respond to GP recommendations for mental health treatment: an analysis of communication in primary care consultations. BJGP Open 3:4, pages bjgpopen19X101670.
Crossref
Crossref
Seung Hwan Lee & Chan-Young Kwon. (2019) A suspected case of somatic symptom disorder improved by herbal medicine: A case report. Complementary Therapies in Clinical Practice 37, pages 68-72.
Crossref
Crossref
James Davies & John Read. (2019) A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive Behaviors 97, pages 111-121.
Crossref
Crossref
Tao Gao, Qianhua Zheng, Tinghui Hou, Yanan Luo, Yunzhou Shi & Ying Li. (2019) Acupuncture for depression: An overview of systematic reviews. European Journal of Integrative Medicine 28, pages 1-13.
Crossref
Crossref
James Davies, John Read, Michael P Hengartner, Fiammetta Cosci, Giovanni Fava, Guy Chouinard, Jim van Os, Antonio Nardi, Peter Gøtzsche, Peter Groot, Emanuela Offidani, Sami Timimi, Joanna Moncrieff, Marcantonio Spada & Anne Guy. (2019) Clinical guidelines on antidepressant withdrawal urgently need updating. BMJ, pages l2238.
Crossref
Crossref
Pramod Krishnappa, Esau Fernandez-Pascual, Joaquin Carballido & Juan Ignacio Martinez-Salamanca. (2019) Sildenafil/Viagra in the treatment of premature ejaculation. International Journal of Impotence Research 31:2, pages 65-70.
Crossref
Crossref
Timothy Wand. (2019) Is it time to end our complicity with pharmacocentricity?. International Journal of Mental Health Nursing 28:1, pages 3-6.
Crossref
Crossref
Jonathan Smithson & Philip B. Mitchell. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
13
26
.
Thomas Gärtner & Ulrich Voderholzer. (2018) Differenzielle Therapieentscheidung bei unipolaren Depressionen. DNP - Der Neurologe & Psychiater 19:6, pages 24-30.
Crossref
Crossref
Tatiana Castillo Parada. (2018) Subjetividad y autonomía: significados y narrativas sobre la discontinuación de fármacos psiquiátricos. Salud Colectiva 14:3, pages 513-529.
Crossref
Crossref
Felicity Thomas, Lorraine Hansford, Joseph Ford, Katrina Wyatt, Rosemarie McCabe & Richard Byng. (2018) Moral narratives and mental health: rethinking understandings of distress and healthcare support in contexts of austerity and welfare reform. Palgrave Communications 4:1.
Crossref
Crossref
Gislaine Olescowicz, Vivian B. Neis, Daiane B. Fraga, Priscila B. Rosa, Dayane P. Azevedo, Fernando Falkenburger Melleu, Patricia S. Brocardo, Joana Gil-Mohapel & Ana Lúcia S. Rodrigues. (2018) Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, pages 395-407.
Crossref
Crossref
Rosemary Basson & Thea Gilks. (2018) Women’s sexual dysfunction associated with psychiatric disorders and their treatment. Women's Health 14, pages 174550651876266.
Crossref
Crossref
Noël HunterNoël Hunter. 2018. Trauma and Madness in Mental Health Services. Trauma and Madness in Mental Health Services
183
199
.
Christien Slofstra, Nicola S. Klein, Maaike H. Nauta, Marieke Wichers, Nikolaos Batalas & Claudi L.H. Bockting. (2017) Imagine your mood: Study design and protocol of a randomized controlled micro-trial using app-based experience sampling methodology to explore processes of change during relapse prevention interventions for recurrent depression. Contemporary Clinical Trials Communications 7, pages 172-178.
Crossref
Crossref
Hao Wang, Ying Zhao, Ying-Jie Wang, Lu Song, Jin-Liang Wang, Chao Huang, Wei Zhang & Bo Jiang. (2017) Antidepressant-like effects of tetrahydroxystilbene glucoside in mice: Involvement of BDNF signaling cascade in the hippocampus. CNS Neuroscience & Therapeutics 23:7, pages 627-636.
Crossref
Crossref
Milutin Kostić & Vanja Mandić-Maravić. (2017) Efficacy of antidepressants: Ten years of meta-analysis Kirša and associate. Psihijatrija danas 49:2, pages 91-106.
Crossref
Crossref